US5759774A
(en)
*
|
1988-05-18 |
1998-06-02 |
Cobe Laboratories, Inc. |
Method of detecting circulating antibody types using dried or lyophilized cells
|
GB8903593D0
(en)
|
1989-02-16 |
1989-04-05 |
Pafra Ltd |
Storage of materials
|
USRE39497E1
(en)
|
1989-02-16 |
2007-02-27 |
Nektar Therapeutics |
Storage of materials
|
US5418130A
(en)
*
|
1990-04-16 |
1995-05-23 |
Cryopharm Corporation |
Method of inactivation of viral and bacterial blood contaminants
|
US6187572B1
(en)
|
1990-04-16 |
2001-02-13 |
Baxter International Inc. |
Method of inactivation of viral and bacterial blood contaminants
|
US5621094A
(en)
*
|
1990-05-14 |
1997-04-15 |
Quadrant Holdings Cambridge Limited |
Method of preserving agarose gel structure during dehydration by adding a non-reducing glycoside of a straight-chain sugar alcohol
|
US5200399A
(en)
*
|
1990-09-14 |
1993-04-06 |
Boyce Thompson Institute For Plant Research, Inc. |
Method of protecting biological materials from destructive reactions in the dry state
|
AU659645B2
(en)
|
1991-06-26 |
1995-05-25 |
Inhale Therapeutic Systems |
Storage of materials
|
GB9125695D0
(en)
*
|
1991-12-03 |
1992-01-29 |
Mastavac Limited |
Medical preparations
|
US5422254A
(en)
*
|
1992-02-14 |
1995-06-06 |
Oy Alko Ab |
Method to increase the trehalose content of organisms by transforming them with the structural genes for the short and long chains of yeast trehalose synthase
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
BR9307141A
(pt)
|
1992-09-29 |
1999-03-30 |
Inhale Therapeutic Syst |
Processo para a liberação sistência pulsátil de um fragmento ativo de hormônio de paratiróide (PTH) para um hospedeiro mamífero e para um paciente e composição farmacêutica
|
US6024090A
(en)
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
PT686045E
(pt)
*
|
1993-02-23 |
2001-04-30 |
Genentech Inc |
Estabilizacao por excipientes de polipeptidos tratados com solventes organicos
|
EP0748213B1
(de)
|
1994-03-07 |
2004-04-14 |
Nektar Therapeutics |
Verfahren und mittel zur verabreichung von insulin über die lunge
|
US5955448A
(en)
|
1994-08-19 |
1999-09-21 |
Quadrant Holdings Cambridge Limited |
Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
|
DE69530196T2
(de)
*
|
1994-06-02 |
2003-11-20 |
Elan Drug Delivery Ltd |
Methode zum verhindern der aggregation von proteinen/peptiden bei rehydratation oder auftauen
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
CZ88697A3
(en)
|
1994-09-22 |
1997-09-17 |
Quadrant Holdings Cambridge |
Composition used for re-hydration and nourishment in the course of athletic outputs and processes for preparing thereof
|
US5556771A
(en)
*
|
1995-02-10 |
1996-09-17 |
Gen-Probe Incorporated |
Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
US6964771B1
(en)
*
|
1995-06-07 |
2005-11-15 |
Elan Drug Delivery Limited |
Method for stably incorporating substances within dry, foamed glass matrices
|
BR9609188A
(pt)
*
|
1995-06-07 |
1999-05-11 |
Quadrant Holdings Cambridge |
Métodos para incorporar substâncias de modo estável dentro de matrizes de vidro espumado secas e composições obtidas desse modo
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
US5762961A
(en)
*
|
1996-02-09 |
1998-06-09 |
Quadrant Holdings Cambridge Ltd. |
Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
|
US5958455A
(en)
*
|
1996-02-09 |
1999-09-28 |
Quadrant Holdings Cambridge Ltd |
Oral solid dosage forms, methods of making same and compositions thereof
|
US6632648B1
(en)
*
|
1996-05-14 |
2003-10-14 |
Elan Drug Delivery Limited |
Methods of terminal sterilization of fibrinogen
|
US6509146B1
(en)
|
1996-05-29 |
2003-01-21 |
Universal Preservation Technologies, Inc. |
Scalable long-term shelf preservation of sensitive biological solutions and suspensions
|
US5876992A
(en)
*
|
1996-07-03 |
1999-03-02 |
Molecular Biology Resources, Inc. |
Method and formulation for stabilization of enzymes
|
US6468782B1
(en)
*
|
1996-12-05 |
2002-10-22 |
Quadrant Healthcare (Uk) Limited |
Methods of preserving prokaryotic cells and compositions obtained thereby
|
DK0967862T3
(da)
|
1997-02-07 |
2003-05-12 |
Elan Drug Delivery Ltd |
Fremgangsmåde og præparater til fremstilling af tørrede, lagringsstabile blodplader
|
TW466116B
(en)
*
|
1997-03-04 |
2001-12-01 |
Hayashibara Biochem Lab |
Reduction inhibitory agent for active-oxygen eliminating activity, method for inhibiting the reduction of said activity, and composition containing said agent
|
IL124275A
(en)
|
1997-05-02 |
2002-03-10 |
Bio Merieux Vitek Inc |
A method to produce sequences of nucleic acids
|
US6558901B1
(en)
|
1997-05-02 |
2003-05-06 |
Biomerieux Vitek |
Nucleic acid assays
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
US6991790B1
(en)
|
1997-06-13 |
2006-01-31 |
Genentech, Inc. |
Antibody formulation
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US7569342B2
(en)
|
1997-12-10 |
2009-08-04 |
Sierra Molecular Corp. |
Removal of molecular assay interferences
|
US6214054B1
(en)
|
1998-09-21 |
2001-04-10 |
Edwards Lifesciences Corporation |
Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
|
US6225289B1
(en)
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
AU776982B2
(en)
*
|
1999-05-04 |
2004-09-30 |
Anhydro Limited |
Method for the preservation of viruses and mycoplasma
|
GB9914412D0
(en)
*
|
1999-06-22 |
1999-08-18 |
Worrall Eric E |
Method for the preservation of viruses,bacteria and biomolecules
|
US6770478B2
(en)
|
2000-02-10 |
2004-08-03 |
The Regents Of The University Of California |
Erythrocytic cells and method for preserving cells
|
EP1255439A4
(de)
|
2000-02-10 |
2007-01-03 |
Univ California |
Therapeutische plättchen und verfahren
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
CA2382133C
(en)
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US6653062B1
(en)
|
2000-07-26 |
2003-11-25 |
Wisconsin Alumni Research Foundation |
Preservation and storage medium for biological materials
|
US7101693B2
(en)
*
|
2001-09-07 |
2006-09-05 |
Brigham Young University |
Plasticized hydrophilic glasses for improved stabilization of biological agents
|
WO2003053411A1
(en)
|
2001-12-19 |
2003-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US6878168B2
(en)
|
2002-01-03 |
2005-04-12 |
Edwards Lifesciences Corporation |
Treatment of bioprosthetic tissues to mitigate post implantation calcification
|
GB0209680D0
(en)
*
|
2002-04-27 |
2002-06-05 |
Univ Strathclyde |
Immobilisation and stabilisation of bacteriophage
|
US20040057969A1
(en)
*
|
2002-09-20 |
2004-03-25 |
Smith Mark L |
Compositions containing stabilized hepatitis antigen and methods of their use
|
GB0225520D0
(en)
*
|
2002-11-01 |
2002-12-11 |
Glaxosmithkline Biolog Sa |
Drying process
|
JP2006504801A
(ja)
*
|
2002-11-01 |
2006-02-09 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
乾燥方法
|
US6927062B2
(en)
*
|
2002-11-25 |
2005-08-09 |
Agdia, Inc. |
Controls and standards for assays and method for manufacture thereof
|
US20050095320A1
(en)
*
|
2003-10-29 |
2005-05-05 |
Richard Botteri |
[An Isotonic Sports Drink for Female Athletes Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Nutrition During Execise and Competition]
|
US20050100636A1
(en)
*
|
2003-11-10 |
2005-05-12 |
Megan Botteri |
[A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity]
|
SG151298A1
(en)
|
2004-04-08 |
2009-04-30 |
Biomatrica Inc |
Integration of sample storage and sample management for life science
|
JP2008507585A
(ja)
*
|
2004-07-26 |
2008-03-13 |
コセリックス インク |
微粒子製剤を用いて吸入したイロプロストによる肺高血圧症の治療
|
DE102005003457B4
(de)
|
2004-07-30 |
2009-12-03 |
IfP Privates Institut für Produktqualität GmbH |
Verfahren und Teilesatz zur mikrobiologischen Bestimmung von Vitamen
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
US8080645B2
(en)
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
US8652782B2
(en)
|
2006-09-12 |
2014-02-18 |
Longhorn Vaccines & Diagnostics, Llc |
Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
|
EP2077718B2
(de)
|
2006-10-27 |
2022-03-09 |
Edwards Lifesciences Corporation |
Biologisches gewebe für chirurgische implantation
|
US20090081639A1
(en)
*
|
2007-05-31 |
2009-03-26 |
Phil Hill |
Assay for sensitivity to chemotherapeutic agents
|
US9101691B2
(en)
|
2007-06-11 |
2015-08-11 |
Edwards Lifesciences Corporation |
Methods for pre-stressing and capping bioprosthetic tissue
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
EP2185196B1
(de)
|
2007-08-27 |
2014-06-11 |
Longhorn Vaccines & Diagnostics, LLC |
Immunogene zusammensetzungen und verfahren
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
ES2552858T3
(es)
|
2007-10-01 |
2015-12-02 |
Longhorn Vaccines And Diagnostics, Llc |
Recogida de muestras biológicas y sistema de transporte y métodos de uso
|
MX2010003613A
(es)
*
|
2007-10-01 |
2010-04-21 |
Omnilytics Inc |
Metodos para secar bacteriofago y composiciones que contienen bacteriofago, las composiciones secas resultantes, y metodos de uso.
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
US8357387B2
(en)
|
2007-12-21 |
2013-01-22 |
Edwards Lifesciences Corporation |
Capping bioprosthetic tissue to reduce calcification
|
PL213166B1
(pl)
*
|
2008-10-29 |
2013-01-31 |
Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk |
Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów
|
CA2761675A1
(en)
|
2009-05-11 |
2010-11-18 |
Biomatrica, Inc. |
Compositions and methods for biological sample storage
|
JP5548436B2
(ja)
*
|
2009-12-17 |
2014-07-16 |
株式会社林原 |
血液寒天培地及びその保存方法
|
NZ602066A
(en)
|
2010-03-23 |
2013-09-27 |
Edwards Lifesciences Corp |
Methods of conditioning sheet bioprosthetic tissue
|
FR2960781B1
(fr)
|
2010-06-07 |
2013-11-22 |
Sanofi Pasteur |
Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue
|
US8906601B2
(en)
|
2010-06-17 |
2014-12-09 |
Edwardss Lifesciences Corporation |
Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
|
US9376709B2
(en)
|
2010-07-26 |
2016-06-28 |
Biomatrica, Inc. |
Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures
|
EP2598661B1
(de)
|
2010-07-26 |
2017-09-27 |
Biomatrica, INC. |
Zusammensetzungen zur stabilisierung von dna, rna und proteinen in speichel- und anderen biologischen proben während des transports und der lagerung bei umgebungstemperaturen
|
WO2012028315A1
(en)
|
2010-09-02 |
2012-03-08 |
Sanofi Pasteur Sa |
A stabilizer for the preparation of a dry polio injectable vaccine composition
|
US9351829B2
(en)
|
2010-11-17 |
2016-05-31 |
Edwards Lifesciences Corporation |
Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
|
CA2836299A1
(en)
|
2011-04-15 |
2012-10-18 |
Genelux Corporation |
Clonal strains of attenuated vaccinia viruses and methods of use thereof
|
EP2806890A4
(de)
|
2012-01-26 |
2015-09-02 |
Longhorn Vaccines & Diagnostics Llc |
Zusammengesetzte antigensequenzen und impfstoffe
|
TWI690322B
(zh)
|
2012-10-02 |
2020-04-11 |
法商傳斯堅公司 |
含病毒的調配物及其使用
|
US20140140959A1
(en)
|
2012-10-05 |
2014-05-22 |
Aladar A. Szalay |
Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes
|
US10238771B2
(en)
|
2012-11-08 |
2019-03-26 |
Edwards Lifesciences Corporation |
Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
|
EP3249054A1
(de)
|
2012-12-20 |
2017-11-29 |
Biomatrica, INC. |
Formulierungen und verfahren zur stabilisierung von pcr-reagenzien
|
CN105530955A
(zh)
|
2013-10-03 |
2016-04-27 |
日东电工株式会社 |
流感疫苗干燥制剂、及流感疫苗干燥制剂的制造方法
|
WO2015103438A2
(en)
|
2014-01-02 |
2015-07-09 |
Genelux Corporation |
Oncolytic virus adjunct therapy with agents that increase virus infectivity
|
JP6661554B2
(ja)
|
2014-06-10 |
2020-03-11 |
バイオマトリカ,インク. |
周囲温度における血小板の安定化
|
CN107614008A
(zh)
*
|
2015-03-20 |
2018-01-19 |
蓝鸟生物公司 |
载体制剂
|
WO2016183292A1
(en)
|
2015-05-14 |
2016-11-17 |
Longhorn Vaccines And Diagnostics, Llc |
Rapid methods for the extraction of nucleic acids from biological samples
|
WO2017100212A1
(en)
|
2015-12-08 |
2017-06-15 |
Biomatrica, Inc. |
Reduction of erythrocyte sedimentation rate
|
CN110300591A
(zh)
*
|
2016-11-04 |
2019-10-01 |
百深公司 |
腺相关病毒制剂
|
WO2024011250A1
(en)
|
2022-07-08 |
2024-01-11 |
Viromissile, Inc. |
Oncolytic vaccinia viruses and recombinant viruses and methods of use thereof
|